A leading genomics company democratizing precision oncology. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. This empowers clinicians to control the sample, data, patient care and economics. Additionally, our products and services enable biopharmaceutical companies to cost-effectively accelerate drug development
Lead Underwriter
BofA Securities, Inc, J.P. Morgan Securities LLC
Co-Managers
Evercore Group L.L.C, Stifel Nicolaus & Company, Incorporated
